Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001610717-25-000106
Filing Date
2025-04-28
Accepted
2025-04-28 18:27:35
Documents
1
Period of Report
2024-08-05

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 4101
  Complete submission text file 0001610717-25-000106.txt   5472
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1 W. FIRST AVENUE CONSHOHOCKEN PA 19428
Business Address
Clyburn Frank (Reporting) CIK: 0001763963 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39219 | Film No.: 25882035